“The apprehension with using non IID shown ingredients is justified as it can be not possible to evaluate if FDA would discover the ‘novel excipient’ Harmless for use in the drug product or service as there's no described approach for analysis and acceptance of excipients. The FDA steering on https://vannevarb394qzh9.empirewiki.com/user